Sio Gene Therapies Inc. Annual Operating Income (Loss) in USD from 2015 to 2021

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Sio Gene Therapies Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2021.
  • Sio Gene Therapies Inc. Operating Income (Loss) for the quarter ending December 31, 2022 was -$4.02M, a 84.2% increase year-over-year.
  • Sio Gene Therapies Inc. Operating Income (Loss) for the twelve months ending December 31, 2022 was -$28.5M, a 53.8% increase year-over-year.
  • Sio Gene Therapies Inc. annual Operating Income (Loss) for 2021 was -$71.6M, a 119% decline from 2020.
  • Sio Gene Therapies Inc. annual Operating Income (Loss) for 2020 was -$32.6M, a 54.8% increase from 2019.
  • Sio Gene Therapies Inc. annual Operating Income (Loss) for 2019 was -$72.2M, a 44% increase from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 -$71.6M -$39M -119% Apr 1, 2021 Mar 31, 2022 10-K 2022-06-14
2020 -$32.6M +$39.6M +54.8% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-14
2019 -$72.2M +$56.7M +44% Apr 1, 2019 Mar 31, 2020 10-K 2021-06-09
2018 -$129M +$91.7M +41.6% Apr 1, 2018 Mar 31, 2019 10-K 2020-06-10
2017 -$221M -$38.6M -21.2% Apr 1, 2017 Mar 31, 2018 10-K 2019-06-11
2016 -$182M -$48.8M -36.7% Apr 1, 2016 Mar 31, 2017 10-K 2018-06-11
2015 -$133M Apr 1, 2015 Mar 31, 2016 10-K 2018-06-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.